The costs of treating febrile neutropenia in six U.K. Hospitals

European Journal of Cancer

Volumn 29, Issue SUPPL. 7, 1993, Pages

  Leese, Brenda ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; ANTIBIOTIC AGENT; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; NYSTATIN; PIPERACILLIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; CANCER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUTROPENIA; PRIORITY JOURNAL;

ANTIBIOTICS; ANTINEOPLASTIC AGENTS; COST OF ILLNESS; DIAGNOSTIC TESTS, ROUTINE; ENGLAND; EPISODE OF CARE; FEVER; GRANULOCYTE COLONY-STIMULATING FACTOR; HOSPITAL COSTS; HUMAN; NEUTROPENIA; ONCOLOGY SERVICE, HOSPITAL; RECOMBINANT PROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0027768916     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(93)90611-I     Document Type: Article

References (15)

1. Neutrophil disorders—benign, quantitative abnormalities of neutrophils
2. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
3. Phase I/II study of recombinant human granulocyte colony stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer
4. Introduction and epidemiology
5. Current guidelines on the use of antibacterial drugs in patients with malignancies
6. Current issues in the antibiotic primary management of the febrile neutropenic cancer patient; a perspective from the National Cancer Institute
7. The problem of neutropenia resulting from cancer therapy
8. Recombinant granulocyte colonystimulating factor. A review of its pharmacological properties and prospective role in neutropenic conditions
9. Decreased costs in cancer chemotherapy patients using recombinant granulocyte colony stimulating factor
10. Cancer therapy complication costly to treat
11. Recombinant granulocyte colonystimulating factor. Pharmacoeconomic considerations in chemotherapy-induced neutropenia
12. Desk top analysers in general medical practice: how useful are they?
13. G-CSF reduces infection and improves delivery of chemotherapy